MARC Record from Deutsche Nationalbibliothek

LEADER: 06026nam a2200697uc 4500
001 1134867611
003 DE-101
005 20200215102736.0
007 cr||||||||||||
008 170608s2012 gw |||||o|||| 00||||eng
015 $a17,O07$2dnb
016 7 $2DE-101$a1134867611
024 7 $a10.1371/journal.pone.0038820$2doi
024 7 $2urn$aurn:nbn:de:bsz:25-freidok-118773
035 $a(DE-599)DNB1134867611
035 $a(OCoLC)992999439
040 $a1240$bger$cDE-101$d9999$erda
041 $aeng
044 $cXA-DE-BW
082 74 $83\p$a617.7$qDE-101$223kdnb
083 7 $84\p$a610$qDE-101$223sdnb
100 1 $0(DE-588)1104515180$0https://d-nb.info/gnd/1104515180$0(DE-101)1104515180$aOterendorp, Christian ˜vanœ$eVerfasser$4aut$2gnd
245 10 $aQuantification of retrograde axonal transport in the rat optic nerve by Fluorogold spectrometry
264 1 $aFreiburg$bUniversität$c2012
300 $aOnline-Ressource
336 $aText$btxt$2rdacontent
337 $aComputermedien$bc$2rdamedia
338 $aOnline-Ressource$bcr$2rdacarrier
500 $aPLoS ONE. 7, 6 (2012), e38820, DOI 10.1371/journal.pone.0038820, issn: 1932-6203
500 $aIN COPYRIGHT http://rightsstatements.org/page/InC/1.0 rs
520 $aAbstract: Purpose<br>Disturbed axonal transport is an important pathogenic factor in many neurodegenerative diseases, such as glaucoma, an eye disease characterised by progressive atrophy of the optic nerve. Quantification of retrograde axonal transport in the optic nerve usually requires labour intensive histochemical techniques or expensive equipment for in vivo imaging. Here, we report on a robust alternative method using Fluorogold (FG) as tracer, which is spectrometrically quantified in retinal tissue lysate.<br><br>Methods<br>To determine parameters reflecting the relative FG content of a sample FG was dissolved in retinal lysates at different concentrations and spectra were obtained. For validation in vivo FG was injected uni- or bilaterally into the superior colliculus (SC) of Sprague Dawley rats. The retinal lysate was analysed after 3, 5 and 7 days to determine the time course of FG accumulation in the retina (n=15). In subsequent experiments axona transport was impaired by optic nerve crush (n=3), laser-induced ocular hypertension (n=5) or colchicine treatment to the SC (n=10).<br><br>Results<br>Spectrometry at 370 nm excitation revealed two emission peaks at 430 and 610 nm. We devised a formula to calculate the relative FG content (cFG), from the emission spectrum. cFG is proportional to the real FG concentration as it corrects for variations of retinal protein concentration in the lysate. After SC injection, cFG monotonously increases with time (p=0.002). Optic nerve axonal damage caused a significant decrease of cFG (crush p=0.029; hypertension p=0.025; colchicine p=0.006). Lysates are amenable to subsequent protein analysis.<br><br>Conclusions<br>Spectrometrical FG detection in retinal lysates allows for quantitative assessment of retrograde axonal transport using standard laboratory equipment. It is faster than histochemical techniques and may also complement morphological in vivo analyses
583 1 $aArchivierung/Langzeitarchivierung gewährleistet$5DE-101$2pdager
650 7 $0(DE-588)4330786-3$0https://d-nb.info/gnd/4330786-3$0(DE-101)940243571$aOptischer Nerv$2gnd
650 7 $0(DE-588)4041649-5$0https://d-nb.info/gnd/4041649-5$0(DE-101)040416496$aNervenzelle$2gnd
650 7 $0(DE-588)4148221-9$0https://d-nb.info/gnd/4148221-9$0(DE-101)041482212$aColliculus superior$2gnd
650 7 $0(DE-588)4148208-6$0https://d-nb.info/gnd/4148208-6$0(DE-101)041482085$aColchicin$2gnd
650 7 $0(DE-588)4026372-1$0https://d-nb.info/gnd/4026372-1$0(DE-101)04026372X$aHypertonie$2gnd
650 7 $81\p$0(DE-588)4003593-1$0https://d-nb.info/gnd/4003593-1$0(DE-101)04003593X$aAugenheilkunde$2gnd
650 7 $82\p$0(DE-588)4112627-0$0https://d-nb.info/gnd/4112627-0$0(DE-101)041126270$aAugenkrankheit$2gnd
653 $aAxonal transport
653 $aRetina ganglion cells
653 $a(local)article
700 1 $0(DE-588)102681152X$0https://d-nb.info/gnd/102681152X$0(DE-101)102681152X$aSgouris, Stavros$d1984-$eVerfasser$4aut$2gnd
700 1 $0(DE-588)1079313974$0https://d-nb.info/gnd/1079313974$0(DE-101)1079313974$aBach, Michael$d1950-$eVerfasser$4aut$2gnd
700 1 $0(DE-588)1130725022$0https://d-nb.info/gnd/1130725022$0(DE-101)1130725022$aMartin, Gottfried$eVerfasser$4aut$2gnd
700 1 $0(DE-588)1044251638$0https://d-nb.info/gnd/1044251638$0(DE-101)1044251638$aBiermann, Julia$eVerfasser$4aut$2gnd
700 1 $0(DE-588)121179109$0https://d-nb.info/gnd/121179109$0(DE-101)121179109$aJordan, Jens F.$d1972-$eVerfasser$4aut$2gnd
700 1 $0(DE-588)1078752281$0https://d-nb.info/gnd/1078752281$0(DE-101)1078752281$aLagrèze, Wolf A.$eVerfasser$4aut$2gnd
710 2 $0(DE-588)1077958293$0https://d-nb.info/gnd/1077958293$0(DE-101)1077958293$aKlinik für Augenheilkunde$gFreiburg im Breisgau$eMitwirkender$4ctb
710 2 $0(DE-588)2120526-7$0https://d-nb.info/gnd/2120526-7$0(DE-101)007677731$aAlbert-Ludwigs-Universität Freiburg$bMedizinische Fakultät$eMitwirkender$4ctb
710 2 $0(DE-588)2024338-8$0https://d-nb.info/gnd/2024338-8$0(DE-101)004816633$aAlbert-Ludwigs-Universität Freiburg$eVerlag$4pbl
850 $aDE-101a$aDE-101b
856 40 $uhttps://doi.org/10.1371/journal.pone.0038820$xResolving-System
856 40 $uhttps://nbn-resolving.org/urn:nbn:de:bsz:25-freidok-118773$xResolving-System
856 0 $uhttps://d-nb.info/1134867611/34$xLangzeitarchivierung Nationalbibliothek
856 4 $qapplication/pdf$uhttps://freidok.uni-freiburg.de/data/11877$zkostenfrei
883 0 $81\p$amaschinell gebildet$c1$d20190525$qDE-101
883 0 $82\p$amaschinell gebildet$c1$d20190525$qDE-101
883 0 $83\p$amaschinell gebildet$c0,96878$d20180813$qDE-101
883 0 $84\p$amaschinell gebildet$c0,998$d20170609$qDE-101
925 r $aro$arb